// App-Quantinova.ai

e17004 : The ACCROBAT I study: Three-year follow-up of a prospective phase II study with neoadjuvant TPF before bioradiotherapy for stage III-IV unresectable squamous cell head and neck cancer.

Researchers

Presenter

  • Clas Mercke

Principal Investigators

  • Helena Sjdin

  • Gabriella von Dobeln

  • Gregori Margolin

  • Mats Hellstrom

  • Jan Nyman

Medical Centers

  • Karolinska Institutet, Stockholm, Sweden

  • Karolinska Institute, Radiumhemmet, Stockholm, SwedenKarolinska Institute, Stockhlm, SwedenSahlgrenska University Hospital, Goeteborg, Sweden

  • Karolinska Institutet, Stockholm, Sweden

  • Department of Oncology, Sahlgrenska University Hospital, Goteborg, Sweden

Locations

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma

  • Squamous cell carcinoma of the head and neck

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Docetaxel

  • Cisplatin

  • Adrucil injection

Outcome

  • Positive

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved